Heron Therapeutics Competitors and Similar CompaniesClear all
Heron Therapeutics's competitors and similar companies include PainReform, JCR Pharmaceuticals, GBT (Global Blood Therapeutics) and Camurus.
 Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. | ||
Founding Date | Founding Date 1983 | Founding Date 2007 | Founding Date 1975 | Founding Date 2012 | Founding Date 1991 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Herzliya, IL HQ Tel Aviv Yafo, IL | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB |
Employees | Employees 20333% decrease | Employees 7 | Employees 934 | Employees 352106% increase | Employees 265 |
Valuation ($) | Valuation ($) 268.5 m | Valuation ($) N/A | Valuation ($) 533.9 m | Valuation ($) 4.4 b | Valuation ($) 3.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $154.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) kr2.3b (FY, 2025) |
Cost of goods | Cost of goods $41.3m (FY, 2025) | Cost of goods N/A | Cost of goods ¥8b (FY, 2025) | Cost of goods $3.3m (FY, 2021) | Cost of goods kr138.7m (FY, 2025) |
Gross profit | Gross profit $113.6m (FY, 2025) | Gross profit N/A | Gross profit ¥25.1b (FY, 2025) | Gross profit N/A | Gross profit kr2.1b (FY, 2025) |
Net income | Net income ($20.2m) (FY, 2025) | Net income N/A | Net income (¥4.7b) (FY, 2025) | Net income ($303.1m) (FY, 2021) | Net income kr735.6m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
PainReform
HQ
Herzliya, IL
Employees
7
PainReform is a pharmaceutical company that develops products for the treatment of pain.
View companyJCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyCamurus
HQ
Lund, SE
Employees
265
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
View company